Big League Genetics Licenses 3R Biotech’s Clean Cannabis Tissue Culture Platform

June 18, 2025 01:05 PM EDT | By EIN Presswire
 Big League Genetics Licenses 3R Biotech’s Clean Cannabis Tissue Culture Platform
Image source: EIN Presswire

Big League Genetics partners with 3R Biotech to eliminate disease risk and scale clean cannabis genetics through a licensed tissue culture platform. VANCOUVER, CANADA, June 18, 2025 /EINPresswire.com/ -- Big League Genetics Licenses 3 Rivers Biotech’s Tissue Culture Platform to Lead in Clean Cannabis Innovation

3R Biotech, a global leader in tissue culture and plant health technologies, has licensed its proprietary cannabis tissue culture platform to Big League Genetics Inc., a subsidiary of 3Win Holdings (Canada) Corp.

“This collaboration represents what’s next for cannabis propagation,” said Robert Allen, CEO of 3 Rivers Biotech. “Big League Genetics is taking proactive steps to secure its genetics, eliminate disease risk, and adopt the kind of scalable, clean plant production the future of this industry demands.”

“Innovation is in our DNA,” said Dave Auger, Commissioner of Big League Genetics. “3R Biotech’s tissue culture platform gives us a cleaner, more reliable foundation, and the freedom to phenohunt a broader range of genetics as we search for the next great flavour.”

As cannabis producers face increasing threats from pathogens like Hop Latent Viroid (HLVd), the demand for clean, consistent starter material is at an unprecedented high. Big League’s investment in tissue culture ensures its genetics remain stable, secure, and ready for scalable deployment in a highly competitive market.

About 3 Rivers Biotech Ltd.
3 Rivers Biotech is a Canadian biotechnology company specializing in tissue culture propagation, disease diagnostics, and clean plant systems. With operations across North America and Europe, 3R Biotech provides turnkey tissue culture labs, validated remediation protocols, advanced qPCR testing services, and proprietary software to help cultivators detect pathogens, eliminate disease, and scale clean, high-performing plants.

About Big League Genetics Inc.
Big League Genetics Inc., a subsidiary of 3Win Holdings (Canada) Corp., is a leading cannabis genetics company dedicated to developing and distributing elite cultivars for the regulated market. Founded in Alberta in 2021, Big League Genetics has already hunted and refined over 100 cultivars (and counting), solidifying its reputation as a trusted partner to licensed producers in Canada and abroad. With a strong focus on innovation, pheno-hunting, and propagation excellence, Big League’s small, dedicated team in Calgary is passionate about delivering consistent, high-quality genetics that growers can trust.

Media Contacts:
Dr. Kevin Mehr
Vice President, 3 Rivers Biotech
[email protected]

Dave Auger
Commissioner, Big League Genetics
[email protected]

Simon James
3R Biotech Ltd.
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media Incorporated (“Kalkine Media, we or us”), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used in the Content are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.